JPMorgan Cuts Ties with Australian Medical Tech Firm 4DMedical

JPMorgan Chase & Co and its affiliates have significantly reduced their stake in Australian medical technology company 4DMedical Ltd. According to a recent filing, JPMorgan has ceased to be a substantial holder in 4DMedical as of September 18, 2026.

The change reflects adjustments across multiple JPMorgan entities acting as lenders, collateral holders, investment managers, and proprietary traders.

Although the reduction is largely mechanical and related to JPMorgan's global asset management and brokerage business, it could modestly impact liquidity and the composition of 4DMedical's shareholder base.